Get started
Author

Clive Dylan Morris

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers
2008 · Alex A. Adjei, Roger B. Cohen, et al. · Journal of Clinical Oncology · 570
PDF
The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer
2010 · Udai Banerji, D. Ross Camidge, et al. · Clinical Cancer Research · 212
A Phase II, Open-Label, Randomized Study to Assess the Efficacy and Safety of AZD6244 (ARRY-142886) Versus Pemetrexed in Patients with Non-small Cell Lung Cancer Who Have Failed One or Two Prior Chemotherapeutic Regimens
2010 · John D. Hainsworth, Cristina L. Cebotaru, et al. · Journal of Thoracic Oncology · 162
PDF
A Phase II, open-label, randomised study to assess the efficacy and safety of the MEK1/2 inhibitor AZD6244 (ARRY-142886) versus capecitabine monotherapy in patients with colorectal cancer who have failed one or two prior chemotherapeutic regimens
2010 · Jaafar Bennouna, Istvan Lang, et al. · Investigational New Drugs · 141
Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer
2019 · Nicolas Guibert, Greg Jones, et al. · Lung Cancer · 106
PDF
Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling
2018 · Vincent Plagnol, Samuel Woodhouse, et al. · PLoS ONE · 94
PDF
Specific inhibition of the endothelin A receptor with ZD4054: clinical and pre-clinical evidence
2005 · C D Morris, A Rose, et al. · British Journal of Cancer · 92
PDF
Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System Progression
2019 · Mihaela Aldea, Lizza Hendriks, et al. · Journal of Thoracic Oncology · 87
PDF
Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial
2022 · Chris Hawkey, Anthony Avery, et al. · The Lancet · 74
PDF
Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation
2001 · C D Morris, J P Byrne, et al. · British journal of surgery · 74
Bicalutamide (‘Casodex’) 150mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: Results from the randomised Early Prostate Cancer Programme
2005 · Chris J. Tyrrell, Heather Payne, et al. · Radiotherapy and Oncology · 71
Real-World Utility of an Amplicon-Based Next-Generation Sequencing Liquid Biopsy for Broad Molecular Profiling in Patients With Advanced Non–Small-Cell Lung Cancer
2019 · Jordi Remon, Ludovic Lacroix, et al. · JCO Precision Oncology · 54
Clinical Relevance of an Amplicon-Based Liquid Biopsy for DetectingALKandROS1Fusion and Resistance Mutations in Patients With Non–Small-Cell Lung Cancer
2020 · Laura Mezquita, Aurélie Swalduz, et al. · JCO Precision Oncology · 52
Prospective Clinical Validation of the InVisionFirst-Lung Circulating Tumor DNA Assay for Molecular Profiling of Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer
2019 · Michael A. Pritchett, D. Ross Camidge, et al. · JCO Precision Oncology · 50
Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with BRAF -Mutant Metastatic Non–Small Cell Lung Cancer
2020 · Sandra Ortiz-Cuaran, Laura Mezquita, et al. · Clinical Cancer Research · 48
Liquid biopsies for residual disease and recurrence
2021 · Jonathan Chee Ming Wan, Tariq Imdadali Mughal, et al. · Med · 46
The Bicalutamide 150 Mg Early Prostate Cancer Program: Findings of the North American Trial at 7.7-Year Median Followup
2006 · David G. McLeod, William A. See, et al. · The Journal of Urology · 46
The Helicobacter Eradication Aspirin Trial (HEAT): A Large Simple Randomised Controlled Trial Using Novel Methodology in Primary Care
2015 · Jennifer S. Dumbleton, Anthony J. Avery, et al. · EBioMedicine · 37
PDF
Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma
2021 · Chul Kim, Liqiang Xi, et al. · Cancers · 26
PDF
Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay
2020 · Jordi Remon, Aurelie Swalduz, et al. · PLoS ONE · 18
PDF
Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer.
2019 · Nicolas Guibert, Greg Jones, et al. · Journal of Clinical Oncology · 18
Who defines Barrett's oesophagus: endoscopist or pathologist?
2001 · Stephen E. A. Attwood, Clive D. Morris · European Journal of Gastroenterology & Hepatology · 15
Exploitation of treatment induced tumor lysis to enhance the sensitivity of ctDNA analysis: A first-in-human pilot study
2022 · Daniel A. Breadner, Mark D. Vincent, et al. · Lung Cancer · 14
Diffuse esophageal leiomyomatosis with localized dense eosinophilic infiltration
2002 · C. D. Morris, J. Wilkinson, et al. · Diseases of the Esophagus · 11
Evaluation of liquid biopsies for molecular profiling in untreated patients with stage III/IV non-small cell lung cancer (NSCLC).
2017 · Benjamin Besse, Jordi Remon, et al. · Journal of Clinical Oncology · 7
Works count: 63
Citation count: 2,170
H-index: 19
I10-index: 24
Year
Topic
Type